Cargando…
Efficacy and safety of oral compared with intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: a meta-analysis
BACKGROUND: Tranexamic acid (TXA) is an anti-fibrinolytic agent successfully preventing blood loss when using intravenously (IV) in total hip arthroplasty (THA) and total knee arthroplasty (TKA). An oral administration, which is available on blood sparing, has been reported exhibit profound cost-sav...
Autores principales: | Han, Xiaozhen, Gong, Guiqing, Han, Naili, Liu, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278110/ https://www.ncbi.nlm.nih.gov/pubmed/30509227 http://dx.doi.org/10.1186/s12891-018-2358-2 |
Ejemplares similares
-
Oral vs intravenous tranexamic acid in total-knee arthroplasty and total hip arthroplasty: A systematic review and meta-analysis
por: Chen, Xuanhuang, et al.
Publicado: (2019) -
The efficacy of oral versus intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: A meta-analysis
por: Wang, Fei, et al.
Publicado: (2018) -
Comparison of intravenous and topical tranexamic acid in total knee arthroplasty
por: Wei, Wenbo, et al.
Publicado: (2018) -
Intravenous Use of Tranexamic Acid in Total Knee Arthroplasty with no Tourniquet
por: Cavalli, Filipe Steimbach, et al.
Publicado: (2023) -
Topical Tranexamic Acid Reduces Postoperative Blood Loss in Primary Total Hip and Knee Arthroplasty
por: Caruthers, Corey M., et al.
Publicado: (2018)